MELISSA FISHER: Open Payments
NPI 1689393530 · FORT WAYNE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$469 in 28 payments from 11 companies in 2025. Trend: 2023 $472 · 2024 $370 · 2025 $469
Food & beverage: $469
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $202 |
| AstraZeneca Pharmaceuticals LP | 4 | $65 |
| Lilly USA, LLC | 2 | $36 |
| Axsome Therapeutics, Inc. | 1 | $24 |
| Exact Sciences Corporation | 1 | $23 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $23 |
| PFIZER INC. | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| Verona Pharma, Inc. | 1 | $19 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
Products named: VRAYLAR, QULIPTA, BREZTRI, UBRELVY, Auvelity, Cologuard Collection Kit, CAPLYTA, VYNDAMAX.
Industry payments across IN — which companies pay providers there.
